Phase 1 Pharmacokinetics of Intravenous Nexium in Children
Completed · Phase 1
Conditions studied: Pharmacokinetics
In brief
The purpose of this research study is to evaluate how much of repeated once daily intravenous (IV, meaning through a vein) doses of esomeprazole gets into the bloodstream of hospitalized children aged 0-17 years old that require acid suppression therapy.
Key facts
- Study ID
- NCT00474019
- Run by
- AstraZeneca
- People needed
- 42
- Starts
- 2007-10-01
- Expected to finish
- 2009-10-01
- Last updated by the study team
- 2010-12-03
Who can join
Age: any, up to 17. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- parent/guardian must sign consent form and the child will be asked to sign and Assent Form if he/she is old enough and is able to sign
- verbal assent will be acceptable if the child is old enough to understand, but unable to write
- female and/or male hospitalized patients aged 0-17 years old who should be considered for treatment with acid suppressive therapy.
You may not qualify if…
- female patients that are pregnant, or plan to become pregnant during the study period or is breast-feeding a child
- patients with a history of multiple drug allergies
- any illness, medical history, abnormal laboratory values, abnormal physical examination findings or abnormal vitals signs that could put the patient at risk when participating in the study
Where it is running
- Research Site — Little Rock, Arkansas, United States
- Research Site — Hartford, Connecticut, United States
- Research Site — Park Ridge, Illinois, United States
- Research Site — Louisville, Kentucky, United States
- Research Site — Detroit, Michigan, United States
- Research Site — Southfield, Michigan, United States
- Research Site — New Brunswick, New Jersey, United States
- Research Site — Buffalo, New York, United States
- Research Site — Cleveland, Ohio, United States
- Research Site — Fort Worth, Texas, United States
- Research Site — Houston, Texas, United States
- Research Site — North Adelaide, South Australia, Australia
- Research Site — Brussels (jette), Belgium, Belgium
- Research Site — Budapest, Hungary
- Research Site — Gothenburg, Sweden
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.